Task: Answer the multiple-choice question.
Question: Which drug exhibits a -6.307% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1nnc(SCC(=O)Nc2nc(C(C)(C)C)cs2)s1
b) CCCCN(NC(C)=O)c1nc(Cl)nc(NC(C)C)n1
Answer: b. CCCCN(NC(C)=O)c1nc(Cl)nc(NC(C)C)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(NC(C)=O)c1nc(Cl)nc(NC(C)C)n1
CCCCN(NC(C)=O)c1nc(Cl)nc(NC(C)C)n1
N'-butyl-N'-[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]acetohydrazide